Since its establishment, Fosun has been deepening its foothold in the health business which has become a pillar sector in Fosun’s ecosystem. The health business of Fosun covers pharmaceutical manufacturing and R&D, healthcare service, medical devices and medical diagnosis, pharmaceutical distribution and retail, health insurance, healthcare management service, health products, etc. Fosun keeps strengthening its globalized industrial operation capability through organic growth, external expansion and integrated development, with a view to building a closed-loop system and forming a complete health ecosystem of the whole industry chain.


The health segment mainly includes Fosun Pharma, Henlius, Fosun Kite, Wanbang Biopharmaceuticals, YAOPHARMA, Guilin Pharma, Gland Pharma, Foshan Chancheng Central Hospital, United Family Healthcare, Sisram Medical, Silver Cross, Fosun United Health Insurance, etc. In recent years, Fosun has been taking technology innovation as its key initiative, while continuously deepening its footholds in the sectors of pharmaceutical manufacturing and R&D, innovative healthcare management service, maternal and nursery products, etc. In pursuit of the vision of “Making every family healthier”, Fosun is committed to creating a C2M happiness ecosystem for success in health business, through leveraging the strategy of “Combining China’s Growth Momentum with Global Resources”, pushing forward innovation in health industry and service upgrade, and providing consumers with comprehensive, personalized and competitive innovative health products and services so as to build a world-class health ecosystem.

  • cainiao-1
  • CM-1
  • Joyview-1
  • tyjlb-1
  • wsyh-3
  • wyjt
  • wyjt